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When Italy introduced a comprehensive ban on smoking in
public places in 2005, it was in the forefront of tobacco control in
Europe, with the pioneers, Ireland and Norway, having done so
only a year previously. The Italian ban achieved very high levels
of compliance,1 attracting strong public support. A Eurobarometer
study conducted in 2009 finding that it was welcomed by 95% of
Italians, more than in any other country in Europe.2
The ban had been introduced in the face of intense opposition
from the tobacco industry. Its arguments took several forms. First,
it enlisted, or in some cases, created, groups purporting to repre-
sent bar and restaurant owners, arguing that a smoking ban would
hit their profits and, possibly, cause them to close. In fact, as a
later systematic review showed, the only research showing that
smoking bans reduced takings were those funded by the tobacco
industry itself.3 Second, it appealed to the concept of personal
freedom, arguing that smokers were being denied the right to do
as they please. Obviously, this disregarded the right of non-smok-
ers to be free from the effects of second-hand smoke. Third, it por-
trayed second-hand smoke as no more than an irritant, with little
or no consequences for health. Moreover, it argued, falsely, that
any irritation could be addressed easily by having separate smok-
ing areas or improve ventilation.4
Tobacco control advocates often use the scream test. The
tobacco industry, with its massive resources, is best placed to
recognise which policies will damage its sales, or as public health
professionals might say, reduce smoking. Consequently, the loud-
er the industry protests about a proposed measure, the more effec-
tive it is likely to be. This was definitely the case with smoking
bans. The industry poured vast resources into lobbying against
them, employing the classic tactics of denialism.5 It engaged in a
major operation to undermine the scientific basis for the bans. For
example, Philip Morris operated a biological testing company in
Germany, kept secret even within the corporation, with communi-
cations passed between the home addresses of those involved
rather than through formal corporate channels.6 The intention was
to create a climate of doubt around the growing evidence linking
second-hand smoke to disease. Of course, the real test of smoking
bans would come when they were implemented. Would they bring
about improvements in health? In fact, the impact was far greater
than almost anyone had anticipated.
The first evidence that smoking bans were having a major
impact on health came from Helena, the capital of Montana. After
it introduced a smoking ban in 2002, hospital admissions for
myocardial infarction fell by 40%.7 This seemed quite remarkable,
however, it should be noted that Helena has a small population and
the confidence intervals were quite wide. Consequently, it was
important to see if these results were replicated elsewhere. And
they were. In Italy, a study in Piedmont reported an 11% drop in
admissions.8 A subsequent study for Italian regions reported 13%
fewer admissions than predicted on the basis of previous trends,
with the decline concentrated among men of working age, who
were most likely to spend time in bars.9 Finally, a nationwide con-
firmed the reduction, and though the overall effect was smaller, it
was again greatest in younger people who are more likely to use
bars.10 In 2014, a report by the US Surgeon General brought the
existing evidence on smoking bans together and concluded that
they were associated with an overall reduction in hospital admis-
sions for myocardial infarction of between 12% and 18%.11
But surely, given this overwhelming evidence, the case for
smoking bans is now firmly established? Apparently not. As
recently as March 2017, one of the regular commentators in the
British newspaper The Times, who also a member of the House of
Lords, dismissed the findings from Helena, describing them as
spurious correlation, before arguing that the vast majority of stud-
ies find no evidence that secondhand smoke causes heart attacks.
The Helena effect was a fluke.13 Meanwhile, the populist UK
Independence Party argues for rescinding the existing smoking
ban.13 Fortunately, as a political party, it is so chaotic that it has no
realistic chance of achieving power. Nonetheless, it is a reminder
of the ability of what is now termed Fake News to gain traction
among sections of the public.
This matters, because the struggle against tobacco is not yet
won. The tobacco industry continues to produce misleading evi-
dence, most recently in relation to the introduction of standardised
packaging. The industry has commissioned reports to cast doubt
on what is now recognised as the tremendous success of this mea-
sure in Australia, by means of highly selective analysis of the
data.14 Many leading journals refuse to publish tobacco industry
funded research, and with good reason.15
There is, however another worry. The tobacco industry is
diversifying. It now dominates the market for electronic cigarettes
and is blurring the boundaries between these products and tradi-
tional cigarettes, with products that heat rather than burn tobacco.
There are considerable concerns about the industry’s role in how
these products are portrayed, and in particular in the production of
the widely quoted, but unsubstantiated claim that they are 95%
safer than ordinary cigarettes,16 a figure that constrasts starkly
with mounting evidence of their harmful effects on the cardiovas-
cular system.17,18 Yet, incredibly, a few tobacco control advocates
seem willing to work with the tobacco industry to promote these
products,19 seemingly unaware of how the industry has used sci-
entists in the past.20
In 2016, Italy introduced a new package of tobacco control
laws, including a ban on smoking in cars transporting children,
prohibition of advertising of electronic cigarettes, and stricter reg-
ulations on tobacco-related litter. These are to be welcomed.
However, there is still more to be done, including a ban on
cigarette vending machines and standardised packaging, to take
Italy once more to the forefront of tobacco control in Europe.
When it does, it can expect strong opposition from the tobacco
industry, which can be expected to produce lots of evidence sup-
porting its case. Given its record, anything it says should be treat-
ed with the most extreme sceptcism.
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